Kura Oncology (KURA) EPS (Basic) (2010 - 2026)
Kura Oncology (KURA) reported EPS (Basic) of -$0.83 for Q1 2026, down 25.76% year-over-year from -$1.12 in Q1 2025, and up 99.06% quarter-over-quarter from -$88.17 in Q3 2025.
Kura Oncology (KURA) EPS (Basic) (2010 - 2026) Analysis & Trends
Kura Oncology (KURA) has 17 years of EPS (Basic) data on file, last reported at -$0.83 in Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.83, down 25.76% year-over-year; the trailing twelve-month figure through Mar 2026 was -$168.32 (down 7915.42% YoY), and the FY2025 annual result was -$3.18, down 57.43% from the prior year.
- EPS (Basic) advanced to -$0.83 in Q1 2026 per KURA's latest filing, from -$88.17 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.22 in Q4 2024 and troughed at -$88.17 in Q3 2025.
- A 5-year average of -$10.9 and a median of -$0.54 in 2022 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) jumped 60.0% in 2024, then tumbled 13895.54% in 2025.
- A 5-year view of EPS (Basic) shows it stood at -$0.49 in 2022, then retreated by 12.24% to -$0.55 in 2023, then jumped by 60.0% to -$0.22 in 2024, then slumped by 39978.15% to -$88.17 in 2025, then jumped by 99.06% to -$0.83 in 2026.
- Business Quant data shows KURA's EPS (Basic) at -$0.83 in Q1 2026, -$88.17 in Q3 2025, and -$78.66 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Kura Oncology | 883.44 Mn | 883.44 Mn | 18.00 Mn | -0.83 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.83 |
| Sep 30, 2025 | -88.17 |
| Jun 30, 2025 | -78.66 |
| Mar 31, 2025 | -0.66 |
| Dec 31, 2024 | -0.22 |
| Sep 30, 2024 | -0.63 |
| Jun 30, 2024 | -0.59 |
| Mar 31, 2024 | -0.59 |
| Dec 31, 2023 | -0.55 |
| Sep 30, 2023 | -0.50 |
| Jun 30, 2023 | -0.53 |
| Mar 31, 2023 | -0.50 |
| Dec 31, 2022 | -0.49 |
| Sep 30, 2022 | -0.53 |
| Jun 30, 2022 | -0.52 |
| Mar 31, 2022 | -0.49 |
| Dec 31, 2021 | -0.50 |
| Sep 30, 2021 | -0.50 |
| Jun 30, 2021 | -0.51 |
| Mar 31, 2021 | -0.46 |